2 results on atopic dermatitis
Approved WMOCompleted
PrimaryTo evaluate the long-term safety and tolerability of baricitinib in patients with SLE.
Approved WMORecruiting
Primary: To describe safety and tolerability during longer-term administration of AR101 and follow-up observation after the last dose of AR101.Secondary: - To assess the level of desensitization achievable through extended maintenance dosing of…